NRICM101
traditional Chinese medicine formula to target COVID-19
NRICM101 (Chinese: 清冠一號; pinyin: Qīngguàn yī hào), is a treatment for COVID-19 developed in Taiwan using Traditional Chinese Medicine (TCM), created by the National Research Institute of Chinese Medicine (NRICM), a governmental body of Taiwan. The prescription has gained legal approval in several countries, the first TCM recipe to do so for COVID-19 treatment. In its native Taiwan, the treatment is used in conjunction with vaccinations. Amongst the formulations available are RespireAid from Sun Ten, and COVRelief from Chuang Song Zong.
The formula is provided in granule form, which is common for Chinese patent medicine.
Formulation
NRICM101 contains 10 herbal medicinal components, including:
黃芩 (Scutellaria baicalensis root)
魚腥草 (Houttuynia cordata, heartleaf)
栝蔞實 (Mongolian snakegourd fruit)
北板藍根 (Indigowoad root)
厚朴 (Magnolia bark)
薄荷 (Peppermint herb)
荊芥 (Fineleaf nepeta)
桑葉 (Mulberry leaf)
防風 (Saposhnikovia root)
甘草 (Baked liquorice root)
Method of action
According to the NRICM, the herbal medicine is supposed to work by preventing the SARS-CoV2 virus from binding with ACE2. This would reduce the chance of severe illness.
Legal status
On 2021 May 18, Taiwan licensed NRICM101 for distribution under emergency access policy.
It is licensed as a herbal drug in Singapore, Thailand, and Australia. It is registered as a herbal granule in the Philippines.
This brief starts where responsible research should: with the source description of “NRICM101” as traditional Chinese medicine formula to target COVID-19. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the science & nature register because the source frames it as traditional Chinese medicine formula to target COVID-19. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Stable identifiers, scientific names and standards terminology offer the best bridge between this overview and specialist evidence. The source revision retrieved here is dated Mar 5, 2026. The linked authority identifier is Q105252811. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2021.
Current terminology should not be projected backward without checking the classification used when the underlying evidence was created. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “NRICM101”, its source revision and the description used here.
- Expand the search: follow NRICM101 primary sources, NRICM101 archive and NRICM101 research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “NRICM101”?
- Which observation, specimen, dataset or publication supports the account?
- Is the terminology current, historical or disputed?
Search terms from this dossier
This entry incorporates text from “NRICM101” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.